Advanced Stage Relapsed Refractory Solid Tumors clinical trials

Explore recruiting advanced stage relapsed refractory solid tumors clinical trials.

Recruiting advanced stage relapsed refractory solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Stage Relapsed Refractory Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A first-in-human, two-part, open-label, clinical study to assess the safety, tolerability, and activity of intravenous doses of ICT01 as monotherapy and in combination with an immune checkpoint inhibitor, in patients with advanced-stage, relapsed/refractory cancer (EVICTION Study)

Belgium, France, Spain, Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1/2, first-in-human, two-part, open-label clinical trial of intravenous administration of CTL-002 given as monotherapy and/or in combination with an anti-PD-1 checkpoint inhibitor in subjects with advanced-stage, relapsed/refractory solid tumors.

Germany, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Advanced Stage Relapsed Refractory Solid Tumors trials by city

Advanced Stage Relapsed Refractory Solid Tumors in Toronto Advanced Stage Relapsed Refractory Solid Tumors in Vancouver Advanced Stage Relapsed Refractory Solid Tumors in Montreal Advanced Stage Relapsed Refractory Solid Tumors in Calgary Advanced Stage Relapsed Refractory Solid Tumors in Edmonton Advanced Stage Relapsed Refractory Solid Tumors in Ottawa Advanced Stage Relapsed Refractory Solid Tumors in Winnipeg Advanced Stage Relapsed Refractory Solid Tumors in Quebec City Advanced Stage Relapsed Refractory Solid Tumors in Hamilton Advanced Stage Relapsed Refractory Solid Tumors in Kitchener Advanced Stage Relapsed Refractory Solid Tumors in London Advanced Stage Relapsed Refractory Solid Tumors in Halifax Advanced Stage Relapsed Refractory Solid Tumors in New York Advanced Stage Relapsed Refractory Solid Tumors in Los Angeles Advanced Stage Relapsed Refractory Solid Tumors in Chicago Advanced Stage Relapsed Refractory Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease